Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: March 2012

Chapter 106 - The causes of convulsive status epilepticus in adults

from Section 5 - Status epilepticus

Summary

Systemic lupus erythematosus (SLE) is the most common collagen vascular disease associated with epilepsy. Various autoantibodies have been implicated in the pathogenesis of neuropsychiatric SLE. Neuropsychiatric involvement is one of the most common clinical features of SLE, with a variable incidence reported between 15% and 75% in adults and between 20% and 85% in children. In SLE, the risk of disease is influenced by complex genetic and environmental contributions: for example, alleles including HLA-DRB1, IRF5, and STAT4 are established susceptibility genes. The diagnosis of SLE is generally a clinical one, supported by laboratory tests. With regard to neurologic involvement, radiologic techniques may be extremely helpful. In the first pediatric SLE (pSLE) study all five children who received either azathioprine or cyclophosphamide in addition to prednisone had a good recovery, while two out of 11 patients treated with prednisone alone died and three other patients had residual neurological defects.

References

Adachi N, Kanemoto K, Muramatsu R, et al. (2005) Intellectual prognosis of status epilepticus in adult epilepsy patients: analysis with Wechsler Adult Intelligence Scale-revised. Epilepsia 46:1502–9.
Alldredge BK, Gelb AM, Isaacs SM, et al. (2001) A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 345:631–7.
Aminoff MJ, Simon RP (1980) Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med 69:657–66.
Bancaud J, Bonis A, Trottier S, Talairach J, Dulac O (1982) L'épilepsie partielle continue: syndrome et maladie. Rev Neurol 138:803–14.
Barry E, Hauser WA (1994) Pleocytosis after status epilepticus. Arch Neurol 51:190–3.
Blennow G, Brierley JB, Meldrum BS, Siesjo BK (1978) Epileptic brain damage: the role of systemic factors that modify cerebral energy metabolism. Brain 101:687–700.
Coeytaux A, Jallon P, Galobardes B, Morabia A (2000) Incidence of status epilepticus in French-speaking Switzerland. Neurology 55:693–7.
Cole AJ (2004) Status epilepticus and periictal imaging. Epilepsia 45(Suppl 4):72–7.
Corey LA, Pellock JM, DeLorenzo RJ (2004) Status epilepticus in a population-based Virginia Twin Sample. Epilepsia 45:159–65.
DeGiorgio CM, Heck CN, Rabinowicz AL, et al. (1999) Serum neuron-specific enolase in the major subtypes of status epilepticus. Neurology 52:746–9.
DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG (1995) Epidemiology of status epilepticus. J Clin Neurophysiol 12:316–25.
DeLorenzo RJ, Hauser WA, Towne AR, et al. (1996) A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46:1029–35.
DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. (1998) Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 39:833–40.
DeLorenzo RJ, Garnett LK, Towne AR, et al. (1999) Comparison of status epilepticus with prolonged seizure episodes lasting from 10–29 minutes. Epilepsia 40:164–9.
Dodson WE, DeLorenzo RJ, Pedley TA, et al. (1993) The treatment of convulsive status epilepticus: recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. J Am Med Ass 270:854–9.
Dworetsky BA, Bromfield EB (2005) Differential diagnosis of status epilepticus: pseudostatus epilepticus. In: Drislane F (ed.) Status Epilepticus: A Clinical Perspective. Totowa, NJ: Humana Press, pp. 33–54.
Fujikawa DG, Shinme SS, Cai B (2000) Kainic acid-induced seizures produce necrotic, not apoptotic, neurons with internucleosomal DNA cleavage: implications for programmed cell death mechanisms. Neuroscience 98:41–53.
Hauser WA (1990) Status epilepticus: epidemiological considerations. Neurology 40(Suppl 2):9–12.
Helmstaedter C (2007) Cognitive outcome of status epilepticus in adults. Epilepsia 48(Suppl 8):85–90.
Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA (1998) Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology 50:735–41.
Holtkamp M, Othman J, Buchheim K, Meierkord H (2005) Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 76:534–9.
Hope O, Blumenfeld H (2005) Cellular phsyiology of status epilepticus. In: Drislane F (ed.) Status Epilepticus: A Clinical Perspective. Totowa, NJ: Humana Press, pp. 159–80.
Hui AC, Joynt GM, Li H, Wong KS (2003) Status epilepticus in Hong Kong Chinese: etiology, outcome and predictors of death and morbidity. Seizure 12:478–82.
Jumao-as A, Brenner RP (1990) Myoclonic status epilepticus: a clinical and electroencephalographic study. Neurology 40:1199–202.
Knake S, Rosenow F, Vescovi M, et al. (2001) Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 42:714–18.
Krumholz A, Stern BJ, Weiss HD (1998) Outcome from coma after cardiopulmonary resuscitation: relation to seizures and myoclonus. Neurology 38:401–5.
Krumholz A, Sung GY, Fisher RS, et al. (1995) Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology 45:1499–504.
Labovitz SL, Hauser WA, Sacco RL (2001) Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology 57:200–6.
Leppik I, Derivan A, Homan R, et al. (1983) Double-blind study of lorazepam and diazepam in status epilepticus. J Am Med Ass 249:1452–4.
Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA (1997) Short-term mortality after a first epilsode of status epilepticus. Epilepsia 38:1344–9.
Logroscino G, Hesdorffer DC, Cascino G (2005) Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia 46(Suppl 11):46–8.
Lothman E (1990) The biochemical basis and pathophysiology of status epilepticus. Neurology 40(Suppl 5):13–23.
Lowenstein DH, Alldredge BK (1993) Status epilepticus at an urban public hospital in the 1980s. Neurology 43:483–98.
Lowenstein DH, Bleck T, MacDonald RL (1999) It's time to revise the definition of status epilepticus. Epilepsia 40:120–2.
Mbodj I, Ndiaye M, Sene F, et al. (2000) Treatment of status epilepticus in a developing country. Neurophysiol Clin 30:165–9.
Meldrum BS, Vigouroux RA, Brierley JB (1973) Systemic factors and epileptic brain damage: prolonged seizures in paralyzed, artificially ventilated baboons. Arch Neurol 28:10–17.
Meierkord H (2007) The risk of epilepsy after status epilepticus in children and adults. Epilepsia 48(Suppl 8):94–5.
Meierkord H, Boon P, Engelsen B, et al. (2006) EFNS guidline on the management of status epilepticus. Eur J Neurol 13:445–50.
Monaghan DT, Cotman DW (1985) Distribution of N-methyl-d-aspartate-sensitive l-(3H)glutamate-binding sites in rat brain. J Neurosci 5:2909–18.
Nair PP, Kalita J, Misra UK (2009) Role of cranial imaging in epileptic status. Eur J Radiol 70:475–80.
Ozawa S, Kamiya H, Tuzuki K (1998) Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 54:581–618.
Pakalnis A, Drake ME, Phillips BB (1991) Neuropsychiatric aspects of psychogenic status epilepticus. Neurology 41:1104–6.
Panayiotopoulos CP, Obeid T, Tahan AR (1994) Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia 35:285–96.
Rossetti AO, Logroscino G, Liaudet L, et al. (2007) Status epilepticus: an independent outcome predictor after cerebral anoxia. Neurology 69:255–60.
Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J (2004) Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia 45:757–63.
Rossetti AO, Oddo M, Liaudet L, Kaplan PW (2009) Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology 72:744–9.
Schomer DL (2005) Focal status epilepticus. In: Drislane F (ed.) Status Epilepticus: A Clinical Perspective. Totowa, NJ: Humana Press, pp. 265–88.
Shorvon S (2008) Controversial topics in epilepsy. Epilepsia 49:1277–84.
Shorvon S, Walker M (2005) Status epilepticus in idiopathic generalized epilepsy. Epilepsia 46(Suppl 9):73–9.
Shorvon S, Baulac M, Cross H, Trinka E, Walker M (2008) The drug treatment of status epilepticus in Europe: consensus document from a workshop at the 1st London Colloquium on Status Epilepticus. Epilepsia 49:1277–85.
Theodore WH, Porter RJ, Albert P, et al. (1994) The secondarily generalized tonic–clonic seizure: a videotape analysis. Neurology 44:1403–7.
Towne AR, Pellock JM, Ko D, DeLorenzo RJ (1994) Determinants of mortality in status epilepticus. Epilepsia 35:27–34.
Treiman DM (1995) Electroclinical features of status epilepticus. J Clin Neurophysiol 12:343–62.
Treiman DM, Walton NY, Kendrick C (1990) A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 5:49–60.
Treiman DM, Meyers PD, Walton NY, et al. (1998) A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 339:792–8.
Velio SK, Ozmeno M, Boz C, Alio Z (2001) Status epilepticus after stroke. Stroke 32:169–72.
Vignatelli L, Tonon C, D'Alessandro R (2003) Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 44:964–8.
Waterhouse E (2005) The epidemiology of status epilepticus. In: Drislane F (ed.) Status Epilepticus: A Clinical Perspective. Totowa, NJ: Humana Press, pp. 55–75.
Waterhouse E (2008) The epidemiology of nonconvulsive status epilepticus. In: Drislane F, Kaplan P (eds.) Nonconvulsive Status Epilepticus. New York: Demos Medical Publishing, pp. 23–40.
Waterhouse EJ, Vaughan JK, Barnes TY, et al. (1998) Synergistic effect of status epilepticus and ischemic brain injury on mortality Epilepsy Res 29:175–83.
Waterhouse EJ, Garnett LK, Towne AR, et al. (1999) Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia. Epilepsia 40:752–8.
Wu YW, Shak DW, Garcia PA, Zhao S, Johnston SC (2002) Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 58:1070–6.
Young GB, Gilber JJ, Zochodne DW (1990) The significance of myoclonic status epilepticus in postanoxic coma. Neurology 40:1843–8.
Zandbergen EG, Hijdra A, Koelman JH, et al. (2006) PROPAC Study Group: prediction of poor outcome within the first three days of postanoxic coma. Neurology 66:62–8.